Impact of upfront chemotherapy on overall survival in isolated myeloid sarcoma

Leukemia. 2021 Apr;35(4):1193-1196. doi: 10.1038/s41375-020-01017-z. Epub 2020 Aug 19.

Authors

Konstantinos Lontos¹, Jonathan G Yabes^{1

2

3}, Rafic J Farah¹, Michael Boyiadzis⁴

Affiliations

¹ UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
² Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
³ Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.
⁴ UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA. boyiadzism@upmc.edu.

PMID: 32814841
DOI: 10.1038/s41375-020-01017-z

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Humans
Prognosis
Sarcoma, Myeloid / diagnosis
Sarcoma, Myeloid / drug therapy*
Sarcoma, Myeloid / mortality*
Treatment Outcome